Holderness Investments Company’s Amgen AMGN Stock Holding History

Holderness Investments Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Buy	8,038 +251	+3%	+$89.5K	0.57%	42
2025 Q4	$2.55M	Buy	7,787 +1	+0%	+$317	0.52%	49
2025 Q3	$2.2M	Buy	7,786 +169	+2%	+$49K	0.45%	57
2025 Q2	$2.13M	Sell	7,617 -25	-0.3%	-$7.08K	0.46%	58
2025 Q1	$2.38M	Buy	7,642 +16	+0.2%	+$4.72K	0.56%	50
2024 Q4	$1.99M	Buy	7,626 +928	+14%	+$275K	0.44%	58
2024 Q3	$2.16M	Buy	6,698 +628	+10%	+$205K	0.47%	53
2024 Q2	$1.9M	Buy	6,070 +485	+9%	+$142K	0.45%	54
2024 Q1	$1.59M	Buy	5,585 +176	+3%	+$51.5K	0.39%	68
2023 Q4	$1.56M	Buy	5,409 +22	+0.4%	+$5.99K	0.43%	64
2023 Q3	$1.45M	Buy	5,387 +44	+0.8%	+$11K	0.56%	47
2023 Q2	$1.19M	Buy	5,343 +162	+3%	+$37.6K	0.44%	57
2023 Q1	$1.25M	Buy	5,181 +266	+5%	+$65.3K	0.5%	55
2022 Q4	$1.29M	Sell	4,915 -10	-0.2%	-$2.68K	0.56%	49
2022 Q3	$1.11M	Hold	4,925	–	–	0.5%	52
2022 Q2	$1.2M	Sell	4,925 -231	-4%	-$56.6K	0.5%	53
2022 Q1	$1.25M	Buy	5,156 +285	+6%	+$65.5K	0.42%	62
2021 Q4	$1.1M	Buy	4,871 +292	+6%	+$61.6K	0.32%	83
2021 Q3	$974K	Buy	4,579 +70	+2%	+$16.1K	0.32%	83
2021 Q2	$1.1M	Buy	4,509 +302	+7%	+$74.3K	0.36%	74
2021 Q1	$1.05M	Buy	4,207 +164	+4%	+$39.1K	0.38%	75
2020 Q4	$930K	Sell	4,043 -1,096	-21%	-$253K	0.36%	73
2020 Q3	$1.31M	Buy	5,139 +37	+0.7%	+$9.17K	0.54%	56
2020 Q2	$1.2M	Sell	5,102 -22	-0.4%	-$5.02K	0.54%	55
2020 Q1	$1.04M	Sell	5,124 -400	-7%	-$87.4K	0.59%	55
2019 Q4	$1.33M	Sell	5,524 -10	-0.2%	-$2.2K	0.57%	52
2019 Q3	$1.07M	Sell	5,534 -170	-3%	-$32.6K	0.5%	58
2019 Q2	$1.05M	Buy	5,704 +50	+0.9%	+$8.95K	0.48%	63
2019 Q1	$1.07M	Sell	5,654 -10	-0.2%	-$1.91K	0.51%	57
2018 Q4	$1.1M	Buy	5,664 +45	+0.8%	+$8.78K	0.6%	52
2018 Q3	$1.17M	Buy	5,619 +35	+0.6%	+$6.9K	0.52%	56
2018 Q2	$1.03M	Sell	5,584 -457	-8%	-$80.8K	0.5%	61
2018 Q1	$1.03M	Buy	6,041 +126	+2%	+$23.1K	0.51%	62
2017 Q4	$1.03M	Buy	5,915 +141	+2%	+$25K	0.51%	62
2017 Q3	$1.08M	Sell	5,774 -121	-2%	-$21.4K	0.56%	58
2017 Q2	$1.01M	Sell	5,895 -113	-2%	-$18.4K	0.54%	61
2017 Q1	$986K	Buy	6,008 +857	+17%	+$142K	0.5%	62
2016 Q4	$753K	Buy	5,151 +215	+4%	+$32.4K	0.67%	56
2016 Q3	$823K	Sell	4,936 -75	-1%	-$12.7K	0.82%	46
2016 Q2	$762K	Sell	5,011 -201	-4%	-$31.3K	0.77%	47
2016 Q1	$781K	Buy	5,212 +54	+1%	+$8.02K	0.74%	50
2015 Q4	$837K	Buy	5,158 +248	+5%	+$39K	0.83%	42
2015 Q3	$679K	Buy	4,910 +79	+2%	+$12.5K	0.71%	51
2015 Q2	$742K	Sell	4,831 -205	-4%	-$32.8K	0.76%	48
2015 Q1	$805K	Sell	5,036 -25	-0.5%	-$3.94K	0.82%	46
2014 Q4	$806K	Buy	+5,061	New	+$789K	0.82%	45

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Holderness Investments Company's AMGN Position: Q1 2026 in Review

Holderness Investments Company increased its Amgen (AMGN) stake by 3.2% in Q1 2026, buying an estimated $89.5K and bringing the position to 8,038 shares worth $2.83M. The position accounts for 0.57% of the portfolio, ranked #42.

Holderness Investments Company first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Holderness Investments Company held 8,038 shares of Amgen worth $2.83M as of Q1 2026.
Holderness Investments Company bought 251 Amgen shares in Q1 2026, an estimated $89.5K.
Amgen made up 0.57% of Holderness Investments Company's portfolio in Q1 2026, its #42 holding.
Holderness Investments Company first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.